Logo image
The biochemical basis of mitochondrial dysfunction in Zellweger Spectrum Disorder
期刊文章   同儕審查

The biochemical basis of mitochondrial dysfunction in Zellweger Spectrum Disorder

Esther Nuebel, Jeffrey T Morgan, Sarah Fogarty, Jacob M Winter, Sandra Lettlova, Jordan A Berg, Yu-Chan Chen, Chelsea U Kidwell, J Alan Maschek, Katie J Clowers, …
EMBO reports, 卷.22(10), 頁碼.e51991-n/a
05/10/2021
PMID: 34351705
Web of Science ID: WOS:000681386500001

摘要

Humans Mitochondria - genetics Peroxins - metabolism Peroxisomal Disorders - genetics Peroxisomal Disorders - metabolism Peroxisomes - metabolism Zellweger Syndrome - genetics Zellweger Syndrome - metabolism
Peroxisomal biogenesis disorders (PBDs) are genetic disorders of peroxisome biogenesis and metabolism that are characterized by profound developmental and neurological phenotypes. The most severe class of PBDs-Zellweger spectrum disorder (ZSD)-is caused by mutations in peroxin genes that result in both non-functional peroxisomes and mitochondrial dysfunction. It is unclear, however, how defective peroxisomes contribute to mitochondrial impairment. In order to understand the molecular basis of this inter-organellar relationship, we investigated the fate of peroxisomal mRNAs and proteins in ZSD model systems. We found that peroxins were still expressed and a subset of them accumulated on the mitochondrial membrane, which resulted in gross mitochondrial abnormalities and impaired mitochondrial metabolic function. We showed that overexpression of ATAD1, a mitochondrial quality control factor, was sufficient to rescue several aspects of mitochondrial function in human ZSD fibroblasts. Together, these data suggest that aberrant peroxisomal protein localization is necessary and sufficient for the devastating mitochondrial morphological and metabolic phenotypes in ZSDs.

檔案與連結 (1)

url
https://doi.org/10.15252/embr.202051991檢視
已出版(紀錄版本) 開放

相關連結

詳細資料

Logo image